Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases

Autor: Hausmann, Jonathan S, Kennedy, Kevin, Simard, Julia F, Liew, Jean W, Sparks, Jeffrey A, Moni, Tarin T, Harrison, Carly, Larché, Maggie J, Levine, Mitchell, Sattui, Sebastian E, Semalulu, Teresa, Foster, Gary, Surangiwala, Salman, Thabane, Lehana, Beesley, Richard P, Durrant, Karen L, Mateus, Elsa F, Mingolla, Serena, Nudel, Michal, Palmerlee, Candace A, Richards, Dawn P, Liew, David FL, Hill, Catherine L, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, Wallace, Zachary S, Yazdany, Jinoos, Sirotich, Emily, COVID-19 Global Rheumatology Alliance

Publikováno v: The Lancet. Rheumatology, vol 3, iss 10

BackgroundThe impact and consequences of the COVID-19 pandemic on people with rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance Patient Experience Survey to assess the effects of the COVID-19 pandemic on people wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::57a7acdd0328821d986ea3af4f7527ad
https://escholarship.org/uc/item/7h50j3rd

Polymyalgia rheumatica immune-related adverse events

Autor: Liew, David FL., Mackie, Sarah L., Tison, Alice, Sattui, Sebastian E., Yates, Max, Buchanan, Russel RC., Owen, Claire E.

Publikováno v: Rheumatic Disease Clinics of North America; 20240101, Issue: Preprints

Designing studies in newly diagnosed versus established polymyalgia rheumatica.

Autor: Liew DF; Department of Rheumatology, Austin Health, Melbourne, VIC 3081, Australia; Department of Clinical Pharmacology and Therapeutics, Austin Health, Melbourne, VIC 3081, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia. Electronic address: david.liew@austin.org.au., Owen CE; Department of Rheumatology, Austin Health, Melbourne, VIC 3081, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.

Publikováno v: The Lancet. Rheumatology [Lancet Rheumatol] 2023 Dec; Vol. 5 (12), pp. e701-e703.

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.

Autor: DiIorio M; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kennedy K; Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada., Liew JW; Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA., Putman MS; Division of Rheumatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Sirotich E; Medicine, McMaster University, Hamilton, Ontario, Canada., Sattui SE; Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Foster G; Department of Health Research Methods, Evidence and Impact (HEI); Medicine, McMaster University, Hamilton, Ontario, Canada., Harrison C; LupusChat, New York, New York, USA., Larché MJ; Divisions of Clinical Immunology and Allergy/Rheumatology, McMaster University Department of Medicine, Hamilton, Ontario, Canada., Levine M; Department of Health Research Methods, Evidence and Impact (HEI), McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada., Moni TT; Department of Biochemistry & Biomedical Sciences, McMaster University Faculty of Science, Hamilton, Ontario, Canada., Thabane L; Department of Health Research Methods, Evidence and Impact (HEI), McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada., Bhana S; Rheumatology, Crystal Run Healthcare, Middletown, New York, USA., Costello W; N/A, Irish Children's Arthritis Network (iCAN), Tipperary, Ireland., Grainger R; Department of Medicine, University of Otago Wellington, Wellington, New Zealand., Machado PM; MRC Centre for Neuromuscular Diseases, University College London, London, UK.; Rheumatology, University College London Centre for Rheumatology, London, UK., Robinson PC; Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.; Metro North Hospital & Health Service, Royal Brisbane and Woman's Hospital Health Service District, Herston, Queensland, Australia., Sufka P; Rheumatology, HealthPartners, St Paul, Minnesota, USA., Wallace ZS; Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Clinical Epidemiology Program and Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA., Yazdany J; Medicine/Rheumatology, University of California, San Francisco, California, USA., Gore-Massy M; Lupus Foundation of America Inc, Washington, District of Columbia, USA., Howard RA; Spondylitis Association of America, Van Nuys, California, USA., Kodhek MA; Lupus Foundation of Kenya, Nairobi, Kenya., Lalonde N; Patient Board, Covid-19 Global Rheumatology Alliance, London, Ontario, Canada., Tomasella LA; Arthritis Kids South Africa, Johannesburg, South Africa., Wallace J; Rheumatology, Autoinflammatory UK, Edinburgh, UK., Akpabio A; Internal Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria., Alpízar-Rodríguez D; Research Unit, Mexican College of Rheumatology, Coyoacan, Mexico., Beesley RP; Juvenile Arthritis Research, European Network for Childhood Arthritis (ENCA), Tonbridge, UK., Berenbaum F; Rheumatology, Sorbonne Université, Paris, France., Bulina I; Rheumatology, Paul Stradins Clinical University Hospital, Riga, Latvia., Chock EY; Section of Rheumatology, Yale School of Medicine, New Haven, Connecticut, USA., Conway R; Department of Rheumatology, Saint James's Hospital, Dublin, Ireland., Duarte-García A; Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA., Duff E; Rheumatology, Saint James's Hospital, Dublin, Ireland., Gheita TA; Rheumatology and Clinical Immunology, Faculty of Medicine, Cairo University, Cairo, Egypt., Graef ER; Rheumatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Hsieh E; Division of Rheumatology, Yale School of Medicine, New Haven, Connecticut, USA.; Rheumatology, VA Connecticut Healthcare System-West Haven Campus, West Haven, Connecticut, USA., El Kibbi L; Internal Medicine Department, Division of Rheumatology, Specialized Medical Center Hospital, Riyadh, Saudi Arabia., Liew DF; Rheumatology, Austin Health, Heidelberg West, Victoria, Australia.; Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg, Victoria, Australia., Lo C; Rheumatology, I-Shou University College of Medicine, Yanchau Sheng, Taiwan., Nudel M; N/A, The Israeli Association for RMDs patients 'Mifrakim Tz'eirim', Haifa, Israel., Singh AD; Department of Community Medicine, Government Medical College Amritsar, Amritsar, Punjab, India.; Rajindra Hospital Patiala, Patiala, Punjab, India., Singh JA; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Medicine Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA., Singh N; Medicine, Division of Rheumatology, University of Washington, Seattle, Washington, USA., Ugarte-Gil MF; School of Medicine, Universidad Cientifica del Sur, Lima, Peru.; Rheumatology, Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru., Hausmann JS; Rheumatology, Boston Children's Hospital, Boston, Massachusetts, USA.; Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Simard JF; Epidemiology and Population Health and Department of Medicine, Division of Immunology & Rheumatology, Stanford School of Medicine, Stanford, California, USA.; Department of Medicine, Clinical Epidemiology Unit, Sweden., Sparks JA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu.; Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Publikováno v: RMD open [RMD Open] 2022 Sep; Vol. 8 (2).

Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study.

Autor: Reid P; Medicine, University of Chicago Biological Sciences Division, Chicago, Illinois, USA pankti.reid@uchospitals.edu., Liew DF; Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.; Division of Rheumatology and Department of Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg, Victoria, Australia., Akruwala R; Department of Medicine, SUNY Downstate Medical Center, New York City, New York, USA., Bass AR; Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA., Chan KK; Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Sep; Vol. 9 (9).